Benzinga - by Lisa Levin, Benzinga Editor. Gainers
- Delcath Systems, Inc. (NASDAQ: DCTH) shares surged 57.7% to $4.93 in pre-market trading after the company reported the FDA approval of HEPZATO KIT™ for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma.
- Sonim Technologies, Inc. (NASDAQ: SONM) rose 29.1% to $0.71 in pre-market trading after the company reported a 125% revenue increase in the second quarter.
- G Medical Innovations Holdings Ltd (NASDAQ: GMVD) shares gained 21% to $0.2299 in pre-market trading after falling over 7% on Monday.
- T2 Biosystems, Inc. (NASDAQ: TTOO) shares gained 18.4% to $0.4619 in pre-market trading after jumping 15% on Monday.
- The Arena Group Holdings, Inc. (NYSE: AREN) shares climbed 18.3% to $4.00 in pre-market trading after the company announced it signed a binding letter of intent to combine with Bridge Media Networks.
- LL Flooring Holdings, Inc. (NYSE: LL) shares rose 12.5% to $4.22 in pre-market trading after the company’s board announced exploration of strategic alternatives, including a sale.
- Castellum, Inc. (NYSE: CTM) rose 10.8% to $0.5320 in pre-market trading after posting better-than-expected quarterly sales.
- Siyata Mobile Inc. (NASDAQ: SYTA) shares rose 10.8% to $3.68 in pre-market trading following upbeat quarterly sales.
- Grove Collaborative Holdings, Inc. (NYSE: GROV) gained 10.5% to $2.42 in pre-market trading after the company posted strong quarterly sales and announced leadership changes.
- Taysha Gene Therapies, Inc. (NASDAQ: TSHA) gained 9.4% to $2.33 in pre-market trading. Taysha Gene Therapies shares jumped 188% on Monday after the company reported initial clinical data from the first adult Rett Syndrome patient dosed in the REVEAL Phase 1/2 trial and announced $150 million private placement financing.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- F45 Training Holdings Inc. (NYSE: FXLV) fell 62.7% to $0.2695 in pre-market trading after the company announced its intent to voluntarily delist and deregister its securities.
- Altisource Asset Management Corporation (NYSE: AAMC) shares fell 61.3% to $12.72 in pre-market trading after the company posted a wider second-quarter loss.
- Alaunos Therapeutics, Inc. (NASDAQ: TCRT) shares fell 49.4% to $0.1993 in pre-market trading after posting a loss for the second quarter.
- Design Therapeutics, Inc. (NASDAQ: DSGN) fell 37.9% to $4.55 in pre-market trading after the company reported second-quarter results and announced initial results from Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich Ataxia.
- MGO Global, Inc. (NASDAQ: MGOL) fell 32.3% to $1.53 in pre-market trading.
- OptimizeRx Corporation (NASDAQ: OPRX) shares fell 22.4% to $9.75 in pre-market trading after posting weak quarterly sales.
- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) fell 22.2% to $0.35 in pre-market trading after the company reported second-quarter results and priced $5 million public offering of common stock.
- Aptevo Therapeutics Inc. (NASDAQ: APVO) fell 21.1% to $0.3554 in pre-market trading. Aptevo Therapeutics recently posted a wider-than-expected quarterly loss.
- Jet.AI Inc. (NASDAQ: JTAI) fell 18.8% to $4.06 in pre-market after declining 25% on Monday.
- Getty Images Holdings, Inc. (NYSE: GETY) fell 18.6% to $3.70 in pre-market trading after the company reported second-quarter earnings.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.